Table of Contents
Vaccines GTCBIO From Political, Socio-Economic, Scientific, Provider, User and Legal Viewpoints October 2-24, 2003
Forward-looking Statement
General Vaccine Targets*
What Are They?
Bioterrorism – Short Term Concern?
Recent History of Development
Government Response
WMD Medical Countermeasures
Project BioShield Status
Project BioShield
Anticipated Federal BioShield Expenditures
Key Concepts for Bio-defense Vaccines
Key Concepts in Biodefense Vaccines
Key Concepts in Biodefense Vaccines
Product Liability
Anthrax Vaccine
Bacillus anthracis Virulence Factors
Asporogenic, Atoxigenic, B. anthracis (?Sterne-1 (pPA102)CR4)
PPT Slide
rPA Vaccine Development Highlights: Year 1
VaxGen’s Manufacturing Capability
Smallpox
PPT Slide
Smallpox
VaxGen’s Smallpox Program Highlights
LC16m8 vs. Other Smallpox Vaccines
Neurotropism of Lister vs. LC16m8
The Role of Bio-defense Vaccines in VaxGen’s Business
PPT Slide
|